InvestorLens

DNA — GINKGO BIOWORKS HOLDINGS INC

Public company

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying DNA?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Strong distribution · 0 buying vs 1 selling last quarter
8
Macro Tailwind
Macro conditions are mixed for this sector
57
Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their DNA position last quarter, 0 bought and 1 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).

Supporting evidence
  • +4 tracked investors reported holding DNA at their latest filing
  • +Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.

About GINKGO BIOWORKS HOLDINGS INC (DNA)

GINKGO BIOWORKS HOLDINGS INC (DNA) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Cathie Wood (ARK Investment Management), valued at $336M. Across recent filings, tracked investors recorded 5 new positions, 2 increased, 4 reduced, and 4 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in DNA

47
/100
Mixed Activity
Added / Increased7
Reduced4
Exited4
BearishBullish
Crowded Trade Score™

How many top investors track DNA

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

DNA Ownership Composition

How GINKGO BIOWORKS HOLDINGS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
74% of tracked value
Institutions
4
tracked investors
Total Reported
$47.8M
combined 13F value
Types3
  • Other74.1%
  • Multi-Strategy / Quant18.9%
  • Macro7.0%
Other(1)
74.1%
Multi-Strategy / Quant(2)
18.9%
Macro(1)
7.0%

Tracked investors currently reporting DNA

2 tracked investors have since exited this position — listed separately below.

  • Andreas HalvorsenJun 30, 2026
    Viking Global Investors
    Shares
    3.6M
    Value
    $35.4M
    % Portfolio
    0.10%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    638.7K
    Value
    $6.3M
    % Portfolio
    0.00%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    274.3K
    Value
    $2.7M
    % Portfolio
    0.00%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    335.7K
    Value
    $3.3M
    % Portfolio
    0.00%

Previously held DNA

These investors reported DNA in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Cathie WoodARK Investment Management23.9M$8MJun 30, 2024
Steve CohenPoint72 Asset Management76.9K$639.1KDec 31, 2025

Recent activity

Frequently asked questions

How many institutional investors hold DNA?
4 tracked institutional investors disclosed a position in DNA (GINKGO BIOWORKS HOLDINGS INC) in their most recent 13F filing.
Who is the largest institutional holder of DNA?
Cathie Wood, ARK Investment Management, holds the largest disclosed position in DNA, valued at $336M.
Did institutional ownership of DNA increase or decrease?
Across recent 13F filings, tracked investors recorded 5 new positions, 2 increased, 4 reduced, and 4 fully exited DNA.
Where does this DNA ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
DNA (GINKGO BIOWORKS HOLDINGS INC) — Institutional Holders — InvestorLens